Americana Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.54M Buy
34,739
+79
+0.2% +$14.9K 0.15% 118
2026
Q1
$6.77M Buy
+34,660
New +$6.68M 0.18% 101
2025
Q4
Sell
-24,917
Closed -$3.82M 477
2025
Q3
$3.82M Buy
24,917
+411
+2% +$62.2K 0.12% 153
2025
Q2
$3.42M Sell
24,506
-279
-1% -$39.1K 0.12% 149
2025
Q1
$3.64M Buy
24,785
+3,424
+16% +$495K 0.14% 128
2024
Q4
$2.8M Buy
21,361
+7,154
+50% +$1M 0.11% 154
2024
Q3
$2.21M Buy
14,207
+198
+1% +$32K 0.15% 136
2024
Q2
$2.19M Buy
14,009
+444
+3% +$66.8K 0.17% 132
2024
Q1
$1.84M Buy
13,565
+957
+8% +$127K 0.15% 137
2023
Q4
$1.7M Sell
12,608
-1,454
-10% -$189K 0.16% 125
2023
Q3
$1.9M Buy
14,062
+1,697
+14% +$232K 0.21% 106
2023
Q2
$1.77M Sell
12,365
-8,386
-40% -$1.23M 0.23% 101
2023
Q1
$2.88M Buy
20,751
+73
+0.4% +$9.82K 0.45% 64
2022
Q4
$2.79M Sell
20,678
-10,119
-33% -$1.27M 0.48% 56
2022
Q3
$3.38M Buy
30,797
+11,746
+62% +$1.49M 0.6% 45
2022
Q2
$2.48M Buy
19,051
+3,971
+26% +$521K 0.44% 69
2022
Q1
$720K Buy
15,080
+4,683
+45% +$562K 0.22% 98
2021
Q4
$1.21M Buy
+10,397
New +$1.22M 0.22% 102
2020
Q1
Sell
-373
Closed -$37K 143
2019
Q4
$37K Buy
+373
New +$35.1K 0.02% 264

Other funds holding AZN

Americana Partners's AZN Position: Q2 2026 in Review

Americana Partners increased its AstraZeneca (AZN) stake by 0.23% in Q2 2026, buying an estimated $14.9K and bringing the position to 34,739 shares worth $6.54M. The position accounts for 0.15% of the portfolio, ranked #118.

Americana Partners first reported a position in AZN in Q4 2019 and has held it in 19 quarters since. The position peaked at $6.77M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Americana Partners held 34,739 shares of AstraZeneca worth $6.54M as of Q2 2026.
  • Americana Partners bought 79 AstraZeneca shares in Q2 2026, an estimated $14.9K.
  • AstraZeneca made up 0.15% of Americana Partners's portfolio in Q2 2026, its #118 holding.
  • Americana Partners first reported a position in AstraZeneca in Q4 2019 and has held it in 19 quarters since.
  • Americana Partners's AstraZeneca position peaked at $6.77M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.